Phase II trial of CLT 008 [purified myeloid progenitor cells] for the prevention of chemotherapy-related complications in patients with acute myeloid leukaemia.
Phase of Trial: Phase II
Latest Information Update: 20 May 2014
At a glance
- Drugs Romyelocel-L (Primary)
- Indications Acute radiation syndrome; Febrile neutropenia; Haematological disorders; Immunocompromised infections
- Focus Therapeutic Use
- 20 May 2014 New trial record